undamentalytics Newsletter

Russell Angus C.: insider trades

Director at 2 companies we cover. 5 open-market purchases and 1 sale not made under a pre-set plan, reported from May 13, 2015 to June 30, 2021.

Would copying Russell Angus C.’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 2 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 14, 2015 into $13,090 by November 2, 2026, +2.4% a year. The copy held shares only 11% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $13,623, +2.7% a year (the S&P 500 held throughout made $43,072, +13.6% a year). Beta against the index was 0.12. Twelve months after each report, the average purchase was +7.6% against the S&P 500 (median +7.6%), and 50% beat it. Measured from the trade date, the insider’s own timing, the average was +13.6%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 201520172019202120232025 $43.1k$13.6k$13.1k
Copying Russell Angus C.S&P 500, same days investedS&P 500, held throughout $10,000 copying Russell Angus C.’s open-market purchases from May 14, 2015, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+2.4%
S&P 500, same days invested
+2.7% (held throughout +13.6%)
Time in shares
11%
Sharpe ratio (S&P 500)
0.10 (0.69)
Biggest drop (S&P 500)
−46% (−34%)
Market sensitivity (beta)
0.12
Purchases copied
2

Trade by trade

Russell Angus C.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 2 +7.8% +7.8% 50% 1 — — Not enough years
Purchases, 6 months after the report 2 +2.5% +2.5% 100% 1 — — Not enough years
Purchases, 12 months after the report 2 +7.6% +7.6% 50% 1 — — Not enough years
Purchases, 12 months after the trade 2 +13.6% +13.6% 100% 1 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Therapeuticsmd, Inc. TXMD —40May 13, 2015August 26, 2019
Lineage Cell Therapeutics, Inc. LCTX —11November 10, 2015June 30, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 30, 2021June 29, 2021 LCTX Sale $14,018 not yetnot yetnot yet
August 26, 2019August 23, 2019 TXMD Purchase $27,700 not yetnot yetnot yet
August 15, 2019August 14, 2019 TXMD Purchase $98,900 not yetnot yetnot yet
November 10, 2015November 6, 2015 LCTX Purchase $191,500 not yetnot yetnot yet
August 27, 2015August 25, 2015 TXMD Purchase $80,730 +18.6%−2.3%+3.1%
May 13, 2015May 12, 2015 TXMD Purchase $215,250 −2.9%+17.6%+24.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Russell Angus C. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.